Misuse of Drugs Act 1971 (Modification) Order 1986
| Jurisdiction | UK Non-devolved |
| Citation | SI 1986/2230 |
| Year | 1986 |
1986 No. 2230
DANGEROUS DRUGS
The Misuse of Drugs Act 1971 (Modification) Order 1986
Made 16th December 1986
Laid before Parliament in draft
Coming into Operation 1st April 1987
At the Court at Buckingham Palace, the 16th day of December 1986
Present,
The Queen's Most Excellent Majesty in Council
Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament:
Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 1971, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:—
1. This Order may be cited as the Misuse of Drugs Act 1971 (Modification) Order 1986 and shall come into operation on 1st April 1987.
2.—(1) Schedule 2 to the Misuse of Drugs Act 1971 (which, as amended1, specifies the drugs which are subject to control under that Act) shall be amended in accordance with the following provisions of this Article.
(2) In paragraph 1 of Part I of that Schedule—
(a)
(a) in sub-paragraph (a) there shall be inserted, after the words the word and after the word the word ; and
(b)
(b) there shall be added at the end the following sub-paragraphs:—
“(d)
“(d) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,
(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;
(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl, groups;
(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
(vi) by replacement of theN-propionyl group by another acyl group;
(e)
(e) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,
(i) by replacement...
To continue reading
Request your trial